KDOQI US Commentary on the 2012 KDIGO Clinical Practice Guideline for Acute Kidney Injury

2012, KDIGO Clinical Practice Guideline for Acute Kidney Injury, Kidney Int Suppl, 2, 1, 10.1038/kisup.2012.1

Levy, 1996, The effect of acute renal failure on mortality, JAMA, 275, 1489, 10.1001/jama.1996.03530430033035

Lassnigg, 2004, Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: a prospective cohort study, J Am Soc Nephrol, 15, 1597, 10.1097/01.ASN.0000130340.93930.DD

Chertow, 2005, Acute kidney injury, mortality, length of stay, and costs in hospitalized patients, J Am Soc Nephrol, 16, 3365, 10.1681/ASN.2004090740

Uchino, 2006, An assessment of the RIFLE criteria for acute renal failure in hospitalized patients, Crit Care Med, 34, 1913, 10.1097/01.CCM.0000224227.70642.4F

Hoste, 2004, Acute renal failure in the critically ill: impact on morbidity and mortality, Contrib Nephrol, 144, 1, 10.1159/000078872

Mehta, 2007, Acute Kidney Injury Network (AKIN): report of an initiative to improve outcomes in acute kidney injury, Crit Care, 11, R31, 10.1186/cc5713

Levin, 2007, Improving outcomes from acute kidney injury: report of an initiative, Am J Kidney Dis, 50, 1, 10.1053/j.ajkd.2007.05.008

Kellum, 2007, The concept of acute kidney injury and the RIFLE criteria, Contrib Nephrol, 156, 10, 10.1159/000102010

Uchino, 2006, The epidemiology of acute renal failure in the world, Curr Opin Crit Care, 12, 538, 10.1097/01.ccx.0000247448.94252.5a

Palevsky, 2008, Intensity of renal support in critically ill patients with acute kidney injury, N Engl J Med, 359, 7, 10.1056/NEJMoa0802639

Bellomo, 2009, Intensity of continuous renal-replacement therapy in critically ill patients, N Engl J Med, 361, 1627, 10.1056/NEJMoa0902413

Lo, 2009, Dialysis-requiring acute renal failure increases the risk of progressive chronic kidney disease, Kidney Int, 76, 893, 10.1038/ki.2009.289

Ishani, 2009, Acute kidney injury increases risk of ESRD among elderly, J Am Soc Nephrol, 20, 223, 10.1681/ASN.2007080837

Wald, 2009, Chronic dialysis and death among survivors of acute kidney injury requiring dialysis, JAMA, 302, 1179, 10.1001/jama.2009.1322

Bucaloiu, 2012, Increased risk of death and de novo chronic kidney disease following reversible acute kidney injury, Kidney Int, 81, 477, 10.1038/ki.2011.405

Wald, 2012, Risk of chronic dialysis and death following acute kidney injury, Am J Med, 125, 585, 10.1016/j.amjmed.2012.01.016

Mehta, 2003, Acute renal failure definitions and classification: time for change?, J Am Soc Nephrol, 14, 2178, 10.1097/01.ASN.0000079042.13465.1A

Bellomo, 2004, Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group, Crit Care, 8, R204, 10.1186/cc2872

Akcan-Arikan, 2007, Modified RIFLE criteria in critically ill children with acute kidney injury, Kidney Int, 71, 1028, 10.1038/sj.ki.5002231

2003, Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project, Qual Saf Health Care, 12, 18, 10.1136/qhc.12.1.18

Brouwers, 2010, AGREE II: advancing guideline development, reporting and evaluation in health care, J Clin Epidemiol, 63, 1308, 10.1016/j.jclinepi.2010.07.001

Ricci, 2008, The RIFLE criteria and mortality in acute kidney injury: a systematic review, Kidney Int, 73, 538, 10.1038/sj.ki.5002743

Friedrich, 2005, Meta-analysis: low-dose dopamine increases urine output but does not prevent renal dysfunction or death, Ann Intern Med, 142, 510, 10.7326/0003-4819-142-7-200504050-00010

Mehta, 2002, Diuretics, mortality, and nonrecovery of renal function in acute renal failure, JAMA, 288, 2547, 10.1001/jama.288.20.2547

Newsome, 2008, Long-term risk of mortality and end-stage renal disease among the elderly after small increases in serum creatinine level during hospitalization for acute myocardial infarction, Arch Intern Med, 168, 609, 10.1001/archinte.168.6.609

Coca, 2010, The duration of postoperative acute kidney injury is an additional parameter predicting long-term survival in diabetic veterans, Kidney Int, 78, 926, 10.1038/ki.2010.259

Chawla, 2011, The severity of acute kidney injury predicts progression to chronic kidney disease, Kidney Int, 79, 1361, 10.1038/ki.2011.42

James, 2011, Associations between acute kidney injury and cardiovascular and renal outcomes after coronary angiography, Circulation, 123, 409, 10.1161/CIRCULATIONAHA.110.970160

Greenbaum, 2011, The association between abnormal birth history and growth in children with CKD, Clin J Am Soc Nephrol, 6, 14, 10.2215/CJN.08481109

Brunkhorst, 2008, Intensive insulin therapy and pentastarch resuscitation in severe sepsis, N Engl J Med, 358, 125, 10.1056/NEJMoa070716

Schortgen, 2001, Effects of hydroxyethylstarch and gelatin on renal function in severe sepsis: a multicentre randomised study, Lancet, 357, 911, 10.1016/S0140-6736(00)04211-2

Myburgh, 2012, Hydroxyethyl starch or saline for fluid resuscitation in intensive care, N Engl J Med, 367, 1901, 10.1056/NEJMoa1209759

Perner, 2012, Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis, N Engl J Med, 367, 124, 10.1056/NEJMoa1204242

Zarychanski, 2013, Association of hydroxyethyl starch administration with mortality and acute kidney injury in critically ill patients requiring volume resuscitation. A systematic review and meta-analysis, JAMA, 309, 678, 10.1001/jama.2013.430

Finfer, 2004, A comparison of albumin and saline for fluid resuscitation in the intensive care unit, N Engl J Med, 350, 2247, 10.1056/NEJMoa040232

Myburgh, 2007, Saline or albumin for fluid resuscitation in patients with traumatic brain injury, N Engl J Med, 357, 874, 10.1056/NEJMoa067514

Gines, 1988, Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis, Gastroenterology, 94, 1493, 10.1016/0016-5085(88)90691-9

Sort, 1999, Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis, N Engl J Med, 341, 403, 10.1056/NEJM199908053410603

Salerno, 2007, Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis, Gut, 56, 1310

Yunos, 2012, Association between a chloride-liberal vs chloride-restrictive intravenous fluid administration strategy and kidney injury in critically ill adults, JAMA, 308, 1566, 10.1001/jama.2012.13356

Shaw, 2012, Major complications, mortality, and resource utilization after open abdominal surgery: 0.9% saline compared to Plasma-Lyte, Ann Surg, 255, 821, 10.1097/SLA.0b013e31825074f5

De Backer, 2010, Comparison of dopamine and norepinephrine in the treatment of shock, N Engl J Med, 362, 779, 10.1056/NEJMoa0907118

De Backer, 2012, Dopamine versus norepinephrine in the treatment of septic shock: a meta-analysis, Crit Care Med, 40, 725, 10.1097/CCM.0b013e31823778ee

Vasu, 2012, Norepinephrine or dopamine for septic shock: systematic review of randomized clinical trials, J Intensive Care Med, 27, 172, 10.1177/0885066610396312

Rivers, 2001, Early goal-directed therapy in the treatment of severe sepsis and septic shock, N Engl J Med, 345, 1368, 10.1056/NEJMoa010307

Lin, 2006, A modified goal-directed protocol improves clinical outcomes in intensive care unit patients with septic shock: a randomized controlled trial, Shock, 26, 551, 10.1097/01.shk.0000232271.09440.8f

Jones, 2007, Prospective external validation of the clinical effectiveness of an emergency department-based early goal-directed therapy protocol for severe sepsis and septic shock, Chest, 132, 425, 10.1378/chest.07-0234

Nguyen, 2006, Early goal-directed therapy, corticosteroid, and recombinant human activated protein C for the treatment of severe sepsis and septic shock in the emergency department, Acad Emerg Med, 13, 109, 10.1111/j.1553-2712.2006.tb00994.x

Rhodes, 2004, Early goal-directed therapy: an evidence-based review, Crit Care Med, 32, S448, 10.1097/01.CCM.0000145945.39002.8D

Crowe, 2010, Evaluation of a modified early goal-directed therapy protocol, Am J Emerg Med, 28, 689, 10.1016/j.ajem.2009.03.007

Brienza, 2009, Does perioperative hemodynamic optimization protect renal function in surgical patients?, Crit Care Med, 37, 2079, 10.1097/CCM.0b013e3181a00a43

Rudis, 1996, Is it time to reposition vasopressors and inotropes in sepsis?, Crit Care Med, 24, 525, 10.1097/00003246-199603000-00026

Egi, 2011, The interaction of chronic and acute glycemia with mortality in critically ill patients with diabetes, Crit Care Med, 39, 105, 10.1097/CCM.0b013e3181feb5ea

Fiaccadori, 2004, Enteral nutrition in patients with acute renal failure, Kidney Int, 65, 999, 10.1111/j.1523-1755.2004.00459.x

Casaer, 2011, Early versus late parenteral nutrition in critically ill adults, N Engl J Med, 365, 506, 10.1056/NEJMoa1102662

Rice, 2012, Initial trophic vs full enteral feeding in patients with acute lung injury: the EDEN randomized trial, JAMA, 307, 795, 10.1001/jama.2012.137

Davies, 2012, A multicenter, randomized controlled trial comparing early nasojejunal with nasogastric nutrition in critical illness, Crit Care Med, 40, 2342, 10.1097/CCM.0b013e318255d87e

Mehta, 2009, Clinical Guidelines: nutrition support of the critically ill child, JPEN J Parenter Enteral Nutr, 33, 260, 10.1177/0148607109333114

Zappitelli, 2008, Protein and calorie prescription for children and young adults receiving continuous renal replacement therapy: a report from the Prospective Pediatric Continuous Renal Replacement Therapy Registry Group, Crit Care Med, 36, 3239, 10.1097/CCM.0b013e31818f3f40

Schetz, 2008, Prevention of cardiac surgery-associated acute kidney injury, Int J Artif Organs, 31, 179, 10.1177/039139880803100211

Solomon, 1994, Effects of saline, mannitol, and furosemide to prevent acute decreases in renal function induced by radiocontrast agents, N Engl J Med, 331, 1416, 10.1056/NEJM199411243312104

Majumdar, 2009, Forced euvolemic diuresis with mannitol and furosemide for prevention of contrast-induced nephropathy in patients with CKD undergoing coronary angiography: a randomized controlled trial, Am J Kidney Dis, 54, 602, 10.1053/j.ajkd.2009.03.024

Brown, 2004, Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?, J Trauma, 56, 1191, 10.1097/01.TA.0000130761.78627.10

Grams, 2011, Fluid balance, diuretic use, and mortality in acute kidney injury, Clin J Am Soc Nephrol, 6, 966, 10.2215/CJN.08781010

Jenik, 2000, A randomized, double-blind, placebo-controlled trial of the effects of prophylactic theophylline on renal function in term neonates with perinatal asphyxia, Pediatrics, 105, E45, 10.1542/peds.105.4.e45

Bakr, 2005, Prophylactic theophylline to prevent renal dysfunction in newborns exposed to perinatal asphyxia—a study in a developing country, Pediatr Nephrol, 20, 1249, 10.1007/s00467-005-1980-z

Bhat, 2006, Theophylline for renal function in term neonates with perinatal asphyxia: a randomized, placebo-controlled trial, J Pediatr, 149, 180, 10.1016/j.jpeds.2006.03.053

Eslami, 2009, Theophylline for prevention of kidney dysfunction in neonates with severe asphyxia, Iran J Kidney Dis, 3, 222

Izquierdo, 2006, Acute renal failure associated with use of inhaled tobramycin for treatment of chronic airway colonization with Pseudomonas aeruginosa, Clin Nephrol, 66, 464, 10.5414/CNP66464

Cannella, 2006, Acute renal failure associated with inhaled tobramycin, Am J Health Syst Pharm, 63, 1858, 10.2146/ajhp060196

Laporta, 2006, Renal toxicity due to inhaled tobramycin in lung transplant recipients, J Heart Lung Transplant, 25, 608, 10.1016/j.healun.2005.10.008

Kleinberg, 2006, What is the current and future status of conventional amphotericin B?, Int J Antimicrob Agents, 27, 12, 10.1016/j.ijantimicag.2006.03.013

Ullmann, 2006, Prospective study of amphotericin B formulations in immunocompromised patients in 4 European countries, Clin Infect Dis, 43, e29, 10.1086/505969

Branch, 1988, Prevention of amphotericin B-induced renal impairment: a review of the use of sodium supplementation, Arch Int Med, 148, 2389, 10.1001/archinte.1988.00380110049010

Thakar, 2005, A clinical score to predict acute renal failure after cardiac surgery, J Am Soc Nephrol, 16, 162, 10.1681/ASN.2004040331

Wijeysundera, 2007, Derivation and validation of a simplified predictive index for renal replacement therapy after cardiac surgery, JAMA, 297, 1801, 10.1001/jama.297.16.1801

Chawla, 2012, Off-pump versus on-pump coronary artery bypass grafting outcomes stratified by preoperative renal function, J Am Soc Nephrol, 23, 1389, 10.1681/ASN.2012020122

Shroyer, 2009, On-pump versus off-pump coronary-artery bypass surgery, N Engl J Med, 361, 1827, 10.1056/NEJMoa0902905

Lamy, 2012, Off-pump or on-pump coronary-artery bypass grafting at 30 days, N Engl J Med, 366, 1489, 10.1056/NEJMoa1200388

Choyke, 1998, Determination of serum creatinine prior to iodinated contrast media: is it necessary in all patients?, Tech Urol, 4, 65

Chertow, 2004, “Renalism”: inappropriately low rates of coronary angiography in elderly individuals with renal insufficiency, J Am Soc Nephrol, 15, 2462, 10.1097/01.ASN.0000135969.33773.0B

Nyman, 2005, Contrast-medium-induced nephropathy correlated to the ratio between dose in gram iodine and estimated GFR in ml/min, Acta Radiol, 46, 830, 10.1080/02841850500335051

Laskey, 2007, Volume-to-creatinine clearance ratio: a pharmacokinetically based risk factor for prediction of early creatinine increase after percutaneous coronary intervention, J Am Coll Cardiol, 50, 584, 10.1016/j.jacc.2007.03.058

Nyman, 2008, Contrast medium dose-to-GFR ratio: a measure of systemic exposure to predict contrast-induced nephropathy after percutaneous coronary intervention, Acta Radiol, 49, 658, 10.1080/02841850802050762

Barrett, 1993, Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media, Radiology, 188, 171, 10.1148/radiology.188.1.8511292

Aspelin, 2003, Nephrotoxic effects in high-risk patients undergoing angiography, N Engl J Med, 348, 491, 10.1056/NEJMoa021833

Heinrich, 2009, Nephrotoxicity of iso-osmolar iodixanol compared with nonionic low-osmolar contrast media: meta-analysis of randomized controlled trials, Radiology, 250, 68, 10.1148/radiol.2501080833

Kushner, 2009, Circulation, 120, 2271, 10.1161/CIRCULATIONAHA.109.192663

Merten, 2004, Prevention of contrast-induced nephropathy with sodium bicarbonate: a randomized controlled trial, JAMA, 291, 2328, 10.1001/jama.291.19.2328

Briguori, 2007, Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies, Circulation, 115, 1211, 10.1161/CIRCULATIONAHA.106.687152

Masuda, 2007, Comparison of usefulness of sodium bicarbonate versus sodium chloride to prevent contrast-induced nephropathy in patients undergoing an emergent coronary procedure, Am J Cardiol, 100, 781, 10.1016/j.amjcard.2007.03.098

Ozcan, 2007, Sodium bicarbonate, N-acetylcysteine, and saline for prevention of radiocontrast-induced nephropathy, Am Heart J, 154, 539, 10.1016/j.ahj.2007.05.012

Pakfetrat, 2009, A comparison of sodium bicarbonate infusion versus normal saline infusion and its combination with oral acetazolamide for prevention of contrast-induced nephropathy: a randomized, double-blind trial, Int Urol Nephrol, 41, 629, 10.1007/s11255-008-9520-y

Recio-Mayoral, 2007, The reno-protective effect of hydration with sodium bicarbonate plus N-acetylcysteine in patients undergoing emergency percutaneous coronary intervention: the RENO Study, J Am Coll Cardiol, 49, 1283, 10.1016/j.jacc.2006.11.034

Brar, 2008, Sodium bicarbonate vs sodium chloride for the prevention of contrast medium-induced nephropathy in patients undergoing coronary angiography: a randomized trial, JAMA, 300, 1038, 10.1001/jama.300.9.1038

Maioli, 2008, Sodium bicarbonate versus saline for the prevention of contrast-induced nephropathy in patients with renal dysfunction undergoing coronary angiography or intervention, J Am Coll Cardiol, 52, 599, 10.1016/j.jacc.2008.05.026

Vasheghani-Farahani, 2009, Sodium bicarbonate plus isotonic saline versus saline for prevention of contrast-induced nephropathy in patients undergoing coronary angiography: a randomized controlled trial, Am J Kidney Dis, 54, 610, 10.1053/j.ajkd.2009.05.016

Brown, 2009, Sodium bicarbonate plus N-acetylcysteine prophylaxis: a meta-analysis, JACC Cardiovasc Interv, 2, 1116, 10.1016/j.jcin.2009.07.015

Zoungas, 2009, Systematic review: sodium bicarbonate treatment regimens for the prevention of contrast-induced nephropathy, Ann Intern Med, 151, 631, 10.7326/0003-4819-151-9-200911030-00008

Navaneethan, 2009, Sodium bicarbonate therapy for prevention of contrast-induced nephropathy: a systematic review and meta-analysis, Am J Kidney Dis, 53, 617, 10.1053/j.ajkd.2008.08.033

Meier, 2009, Sodium bicarbonate-based hydration prevents contrast-induced nephropathy: a meta-analysis, BMC Med, 7, 23, 10.1186/1741-7015-7-23

Hoste, 2010, Sodium bicarbonate for prevention of contrast-induced acute kidney injury: a systematic review and meta-analysis, Nephrol Dial Transplant, 25, 747, 10.1093/ndt/gfp389

Joannidis, 2008, Prevention of contrast media-induced nephropathy by isotonic sodium bicarbonate: a meta-analysis, Wien Klin Wochenschr, 120, 742, 10.1007/s00508-008-1117-z

Hogan, 2008, Current role of sodium bicarbonate-based preprocedural hydration for the prevention of contrast-induced acute kidney injury: a meta-analysis, Am Heart J, 156, 414, 10.1016/j.ahj.2008.05.014

Ho, 2008, Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: a meta-analysis, Anaesth Intensive Care, 36, 646, 10.1177/0310057X0803600503

Kanbay, 2009, Sodium bicarbonate for the prevention of contrast-induced nephropathy: a meta-analysis of 17 randomized trials, Int Urol Nephrol, 41, 617, 10.1007/s11255-009-9569-2

Kunadian, 2011, Sodium bicarbonate for the prevention of contrast induced nephropathy: a meta-analysis of published clinical trials, Eur J Radiol, 79, 48, 10.1016/j.ejrad.2009.12.015

Brar, 2009, Sodium bicarbonate for the prevention of contrast induced-acute kidney injury: a systematic review and meta-analysis, Clin J Am Soc Nephrol, 4, 1584, 10.2215/CJN.03120509

Briguori, 2011, Renal Insufficiency After Contrast Media Administration Trial II (REMEDIAL II): RenalGuard System in high-risk patients for contrast-induced acute kidney injury, Circulation, 124, 1260, 10.1161/CIRCULATIONAHA.111.030759

Marenzi, 2012, Prevention of contrast nephropathy by furosemide with matched hydration: the MYTHOS (Induced Diuresis With Matched Hydration Compared to Standard Hydration for Contrast Induced Nephropathy Prevention) trial, JACC Cardiovasc Interv, 5, 90, 10.1016/j.jcin.2011.08.017

Tepel, 2000, Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine, N Engl J Med, 343, 180, 10.1056/NEJM200007203430304

Baker, 2003, A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study, J Am Coll Cardiol, 41, 2114, 10.1016/S0735-1097(03)00487-X

Balderramo, 2004, Renoprotective effect of high periprocedural doses of oral N-acetylcysteine in patients scheduled to undergo a same-day angiography, Rev Fac Cien Med Univ Nac Cordoba, 61, 13

Diaz-Sandoval, 2002, Acetylcysteine to Prevent Angiography-Related Renal Tissue Injury (the APART trial), Am J Cardiol, 89, 356, 10.1016/S0002-9149(01)02243-3

Drager, 2004, Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury, Nephrol Dial Transplant, 19, 1803, 10.1093/ndt/gfh261

Kay, 2003, Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial, JAMA, 289, 553, 10.1001/jama.289.5.553

MacNeill, 2003, Prophylaxis of contrast-induced nephropathy in patients undergoing coronary angiography, Catheter Cardiovasc Interv, 60, 458, 10.1002/ccd.10684

Marenzi, 2006, N-Acetylcysteine and contrast-induced nephropathy in primary angioplasty, N Engl J Med, 354, 2773, 10.1056/NEJMoa054209

Miner, 2004, N-Acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up, Am Heart J, 148, 690, 10.1016/j.ahj.2004.05.015

Ochoa, 2004, Abbreviated dosing of N-acetylcysteine prevents contrast-induced nephropathy after elective and urgent coronary angiography and intervention, J Interv Cardiol, 17, 159, 10.1111/j.1540-8183.2004.09880.x

Shyu, 2002, Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure, J Am Coll Cardiol, 40, 1383, 10.1016/S0735-1097(02)02308-2

Allaqaband, 2002, Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy, Catheter Cardiovasc Interv, 57, 279, 10.1002/ccd.10323

Amini, 2009, N-Acetylcysteine does not prevent contrast-induced nephropathy after cardiac catheterization in patients with diabetes mellitus and chronic kidney disease: a randomized clinical trial, Trials, 10, 45, 10.1186/1745-6215-10-45

Azmus, 2005, Effectiveness of acetylcysteine in prevention of contrast nephropathy, J Invasive Cardiol, 17, 80

Briguori, 2002, Acetylcysteine and contrast agent-associated nephrotoxicity, J Am Coll Cardiol, 40, 298, 10.1016/S0735-1097(02)01958-7

Carbonell, 2007, Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial, Int J Cardiol, 115, 57, 10.1016/j.ijcard.2006.04.023

Coyle, 2006, Acetylcysteine In Diabetes (AID): a randomized study of acetylcysteine for the prevention of contrast nephropathy in diabetics, Am Heart J, 151, 1032.e9, 10.1016/j.ahj.2006.02.002

Durham, 2002, A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography, Kidney Int, 62, 2202, 10.1046/j.1523-1755.2002.00673.x

Fung, 2004, Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial, Am J Kidney Dis, 43, 801, 10.1053/j.ajkd.2004.01.010

Goldenberg, 2004, Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography, Eur Heart J, 25, 212, 10.1016/j.ehj.2003.11.011

Gomes, 2005, N-Acetylcysteine does not prevent contrast induced nephropathy after cardiac catheterisation with an ionic low osmolality contrast medium: a multicentre clinical trial, Heart, 91, 774, 10.1136/hrt.2004.039636

Kefer, 2003, Acetylcysteine, coronary procedure and prevention of contrast-induced worsening of renal function: which benefit for which patient?, Acta Cardiol, 58, 555, 10.2143/AC.58.6.2005321

Oldemeyer, 2003, Acetylcysteine in the prevention of contrast-induced nephropathy after coronary angiography, Am Heart J, 146, E23, 10.1016/S0002-8703(03)00511-8

Rashid, 2004, Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine, J Vasc Surg, 40, 1136, 10.1016/j.jvs.2004.09.026

Sandhu, 2006, The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity, Cardiovasc Intervent Radiol, 29, 344, 10.1007/s00270-005-0127-8

Webb, 2004, A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect, Am Heart J, 148, 422, 10.1016/j.ahj.2004.03.041

Kelly, 2008, Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy, Ann Intern Med, 148, 284, 10.7326/0003-4819-148-4-200802190-00007

Gonzales, 2007, A meta-analysis of N-acetylcysteine in contrast-induced nephrotoxicity: unsupervised clustering to resolve heterogeneity, BMC Med, 5, 32, 10.1186/1741-7015-5-32

Vaitkus, 2007, N-Acetylcysteine in the prevention of contrast-induced nephropathy: publication bias perpetuated by meta-analyses, Am Heart J, 153, 275, 10.1016/j.ahj.2006.09.014

Trivedi, 2009, High-dose N-acetylcysteine for the prevention of contrast-induced nephropathy, Am J Med, 122, 10.1016/j.amjmed.2009.01.035

2011, Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT), Circulation, 124, 1250, 10.1161/CIRCULATIONAHA.111.038943

Stone, 2003, Fenoldopam mesylate for the prevention of contrast-induced nephropathy: a randomized controlled trial, JAMA, 290, 2284, 10.1001/jama.290.17.2284

Dai, 2012, Effect of theophylline on prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials, Am J Kidney Dis, 60, 360, 10.1053/j.ajkd.2012.02.332

Cruz, 2012, Renal replacement therapies for prevention of radiocontrast-induced nephropathy: a systematic review, Am J Med, 125, 66, 10.1016/j.amjmed.2011.06.029

Parienti, 2008, Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial, JAMA, 299, 2413, 10.1001/jama.299.20.2413

Barenbrock, 2000, Effects of bicarbonate- and lactate-buffered replacement fluids on cardiovascular outcome in CVVH patients, Kidney Int, 58, 1751, 10.1046/j.1523-1755.2000.00336.x

McLean, 2000, Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction, Kidney Int, 58, 1765, 10.1046/j.1523-1755.2000.00338.x

Thomas, 1997, Comparison of lactate and bicarbonate buffered haemofiltration fluids: use in critically ill patients, Nephrol Dial Transplant, 12, 1212, 10.1093/ndt/12.6.1212

Gotch, 2000, Whither goest Kt/V?, Kidney Int Suppl, 76, S3, 10.1046/j.1523-1755.2000.07602.x

Evanson, 1998, Prescribed versus delivered dialysis in acute renal failure patients, Am J Kidney Dis, 32, 731, 10.1016/S0272-6386(98)70127-1

Venkataraman, 2002, Dosing patterns for continuous renal replacement therapy at a large academic medical center in the United States, J Crit Care, 17, 246, 10.1053/jcrc.2002.36757

Overberger, 2007, Management of renal replacement therapy in acute kidney injury: a survey of practitioner prescribing practices, Clin J Am Soc Nephrol, 2, 623, 10.2215/CJN.00780207

Vesconi, 2009, Delivered dose of renal replacement therapy and mortality in critically ill patients with acute kidney injury, Crit Care, 13, R57, 10.1186/cc7784

Tolwani, 2006, A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance, Clin J Am Soc Nephrol, 1, 79, 10.2215/CJN.00040505

Tolwani, 2012, Regional citrate anticoagulation for continuous renal replacement therapy: the better alternative?, Am J Kidney Dis, 59, 745, 10.1053/j.ajkd.2012.03.003

Link, 2009, Argatroban for anticoagulation in continuous renal replacement therapy, Crit Care Med, 37, 105, 10.1097/CCM.0b013e3181932394

Tolwani, 2009, Anticoagulation for continuous renal replacement therapy, Semin Dial, 22, 141, 10.1111/j.1525-139X.2008.00545.x

Klouche, 2007, Complications, effects on dialysis dose, and survival of tunneled femoral dialysis catheters in acute renal failure, Am J Kidney Dis, 49, 99, 10.1053/j.ajkd.2006.09.014

Davenport, 1987, Continuous arteriovenous haemofiltration in patients with hepatic encephalopathy and renal failure, Br Med J, 295, 1028, 10.1136/bmj.295.6605.1028

Davenport, 1987, Haemofiltration in management of patients with acute renal failure complicated by raised intracranial pressure, Lancet, 1, 216, 10.1016/S0140-6736(87)90027-4

Davenport, 1990, Early changes in intracranial pressure during haemofiltration treatment in patients with grade 4 hepatic encephalopathy and acute oliguric renal failure, Nephrol Dial Transplant, 5, 192, 10.1093/ndt/5.3.192

Davenport, 1991, Continuous vs. intermittent forms of haemofiltration and/or dialysis in the management of acute renal failure in patients with defective cerebral autoregulation at risk of cerebral oedema, Contrib Nephrol, 93, 225, 10.1159/000420225